康芝藥業(300086.SZ):實控人減持期屆滿 擬繼續減持不超393.25萬股
格隆匯5月8日丨康芝藥業(300086.SZ)公佈,近日,公司收到洪江遊《股份減持計劃期限屆滿的告知函》及《股份減持計劃告知函》,截至公告披露日,減持計劃期限已屆滿,雲南國際信託有限公司-聚鑫2026號集合資金信託計劃未減持公司股份。截至公告日,洪江遊此次減持計劃實施期限已經屆滿,其在減持計劃期限內未減持公司股份。
洪江遊,其直接持有公司股份768.7萬股(佔公司總股本比例1.71%),通過雲南國際信託有限公司-聚鑫2026號集合資金信託計劃間接持有公司股份393.25萬股(佔公司總股本比例0.87%),通過海南宏氏投資有限公司間接持有公司股份1.11億股(佔公司總股本比例24.77%),合計持有公司股份1.23億股(佔公司總股本比例27.35%),為公司實際控制人及董事長。
雲南國際信託有限公司-聚鑫2026號集合資金信託計劃擬自減持計劃公告之日起15個交易日後的未來6個月內(法定禁止期間除外)通過大宗交易、二級市場集中競價減持不超過393.25萬股,佔公司總股份比例不超過0.87%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.